Jang Ki Yong and Ahn Eun Jin may be starring in a new drama together! On October 17, media outlets reported that Jang Ki Yong and Ahn Eun Jin will be starring in the new SBS drama “Shouldn’t ...

Eli Lilly has seen massive returns this year and is one of the most expensive healthcare stocks in the world. Its new products have strong growth prospects, but their potential may still be ...

She expected to see some fans from her pop-up days, but what Jiyoon Jang didn’t foresee were lines out the door, countless new faces and selling out every single day. After years of popping up ...

Renowned actor Jang Shin-young, who faced a challenging period following her husband and actor Kang Kyung-joon's infidelity scandal, opened up about her emotional struggles during an appearance on ...

Paulo Nunes dos Santos / Bloomberg via Getty Images Eli Lilly will report third-quarter earnings Wednesday morning, with the focus remaining on the production and sales of its popular weight-loss ...

A change in the dosing regimen of Eli Lilly’s Alzheimer’s drug Kisunla resulted in a lower rate of brain swelling among patients in a clinical trial, new data reported Tuesday show.

Eli Lilly is expanding its innovation digs to Beijing, opening two research centers called the Eli Lilly China Medical Innovation Center and Lilly Gateway Labs. The newest Gateway Lab is the ...

Shares of Eli Lilly have gained considerably throughout 2024, thanks in large part to the company's success in diabetes and obesity care. Outside of weight loss, Eli Lilly has a major opportunity ...

Veteran corner back Eli Apple is set to be signed by the Los Angeles Chargers, according to NFL Network's Tom Pelissero. Tom Pelissero @TomPelissero The <a href ...

CINCINNATI — Former Bengals cornerback Eli Apple is back in the NFL. The veteran is signing with the Chargers after working out for the team on Monday. Apple will start out on the practice squad ...

Upon a comprehensive analysis of Eli Lilly, the following trends can be discerned: The Price to Earnings ratio of 112.95 for this company is 4.17x above the industry average, indicating a premium ...